Structural Studies on Intact Clostridium Botulinum Neurotoxins Complexed with Inhibitors Leading to Drug Design
Abstract
In this third annual report we present our progress on two different areas. We have identified two ganglioside binding sites in tetanus toxin. While one is common to botulinum toxins, the other is unique for tetanus. The second unique site also binds a tri-peptide which suggests that this peptide could be used as an inhibitor for tetanus, at least. We have determined the structure of the C fragment of botulinum neurotoxin type B. We have identified a number of inactive mutants of BoNT/E-LC. Some of these mutants may be potential candidates for vaccines. Most importantly, for the first time we have shown that Glu335Gln mutant of BoNT/E-LC is an apoenzyme devoid of zinc.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2005
- Accession Number
- ADA432038
Entities
People
- Subramanyam Swaminathan
Organizations
- Brookhaven National Laboratory